Research innovation
Our Health 25 Strategy spans disciplines, locations and industries to convert our research innovations into results that truly matter.
鈥淭he value of human endeavour is magnified when you bring together different view points and complementary expertise. It is only through our partnerships with industry, government and community that we will be able to tackle today鈥檚 global health challenges.鈥
听
Professor Phoebe Phillips, Associate Dean Partnerships and Engagement, 麻豆社madou Medicine and Health听
听
Partnership highlight
The 麻豆社madou RNA Institute, Australia鈥檚 leading RNA science, therapeutics and translational facility, has officially opened. Established with a $25 million investment from 麻豆社madou Sydney as part of a NSW RNA Bioscience Alliance between NSW universities and the State Government, the Institute will build NSW鈥檚 capability to research, develop and manufacture RNA-based therapeutics locally.
听
Partnership highlight
麻豆社madou Sydney and the Garvan Institute of Medical Research researchers will lead the pancreatic cancer clinical trial program, thanks to a $3.75 million grant from the Cancer Institute NSW.
Partnerships magnify our ability to make a positive impact in medicine and healthcare. Under our Health 25 Strategy Partnerships has been identified as a pillar of our success as a faculty as we strive to improve health in Australia and globally 鈥 with a focus on eliminating health disparities and tackling the most difficult problems in medicine and public health. We know that we can make the biggest impact by working with others who are also excellent in their field.
Contact us
Find out more about partnering with 麻豆社madou Medicine & Health.